Name
Tartu Loomakliinik OÜ
Registry code
14821628
VAT number
EE102196922
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.10.2019 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
75001 - Veterinary activities
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Aleksandr Dedjulja 05.09.1988 (36) | 50% - 1 250.00 EUR | Board member | Direct ownership | Founder |
| Kersti Paju 24.12.1980 (43) | 50% - 1 250.00 EUR | Board member | Direct ownership | Founder |
| 2020 25.03.2021 | 2021 30.06.2022 | 2022 30.06.2023 | |
|---|---|---|---|
| Total Revenue | 450 333 € | 713 808 € | 955 540 € |
| Net profit (loss) for the period | 15 877 € | 67 837 € | 115 776 € |
| Profit Margin | 4% | 10% | 12% |
| Current Assets | 81 882 € | 84 501 € | 175 307 € |
| Fixed Assets | 99 122 € | 140 705 € | 148 090 € |
| Total Assets | 181 004 € | 225 206 € | 323 397 € |
| Current Liabilities | 41 616 € | 89 461 € | 99 374 € |
| Non Current Liabilities | 121 011 € | 49 566 € | 50 194 € |
| Total Liabilities | 162 627 € | 139 027 € | 149 568 € |
| Share Capital | - | - | - |
| Equity | 18 377 € | 86 179 € | 173 829 € |
| Employees | 5 | 10 | 11 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 359 364.19 € | 92 943.5 € | 66 172.23 € | 25 |
| 2023 Q4 | 354 889.14 € | 97 665.54 € | 54 183.81 € | 25 |
| 2023 Q3 | 352 487.16 € | 80 349.01 € | 49 358.54 € | 23 |
| 2023 Q2 | 319 109.89 € | 68 874.91 € | 43 183.19 € | 20 |
| 2023 Q1 | 267 983.56 € | 48 713.22 € | 37 599.41 € | 18 |
| 2022 Q4 | 268 841.87 € | 57 114.51 € | 32 487.05 € | 15 |
| 2022 Q3 | 247 409.89 € | 61 472.54 € | 28 089.8 € | 16 |
| 2022 Q2 | 246 882.83 € | 57 672.19 € | 28 980.84 € | 12 |
| 2022 Q1 | 209 561.63 € | 47 580.73 € | 28 076.68 € | 12 |
| 2021 Q4 | 189 612.88 € | 40 263.13 € | 22 704.87 € | 13 |
| 2021 Q3 | 193 440.54 € | 38 428.04 € | 24 586.17 € | 12 |
| 2021 Q2 | 197 865.93 € | 34 330.76 € | 17 553.29 € | 11 |
| 2021 Q1 | 154 764.06 € | 32 461.33 € | 16 575.18 € | 8 |
| 2020 Q4 | 147 943.69 € | 28 791.56 € | 13 629.87 € | 7 |
| 2020 Q3 | 137 285.78 € | 24 672.69 € | 11 620.24 € | 7 |
| 2020 Q2 | 98 062.62 € | 16 414.88 € | 6 620.04 € | 7 |
| 2020 Q1 | 74 545.68 € | - | 2 857.47 € | 6 |
